Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/9/2020
SIETES contiene 93096 citas

 1 a 20 de 32 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Walter SR, Day RO, Gallego B, Westbrook JI. The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia. Br J Clin Pharmacol 2017;83:416-26. [Ref.ID 101933]
2.Tiene citas relacionadas Cita con resumen
Mathieson S, Chiro M, Maher CG, LcLachlan AJ, Latimer J, Koes BW, Hancock MJ, Harris I, Day RO, Billot L, Pik J, Jan S, Lin C-WC. Trial of pregabalin for acute and chronic sciatica. N Engl J Med 2017;376:1111-20. [Ref.ID 101483]
3. Cita con resumen
Machado GC, Maher CG, Herreira PH, Day RO, Pinheiro MB, Ferreira ML. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis 2017;76:1269-78. [Ref.ID 101391]
4.Enlace a cita original Cita con resumen
Day RO, Snowden L. Where to find information about drugs. Australian Prescriber 2016;39:88-95. [Ref.ID 100343]
5.Tiene citas relacionadas Cita con resumen
Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin C-WC, Day RO, McLachlan AJ, Ferreira ML. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ 2015;350:h1225. [Ref.ID 98890]
6.Tiene citas relacionadas Cita con resumen
Williams CM, Maher CG, Latimer J, McLachian AJ, Hancock MJ, Day RO, Lin C-WC. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet 2014;384:1586-96. [Ref.ID 98303]
7. Cita con resumen
Ramasamy SN, Korb-Wells CS, Kannangara DRW, Smith MWH, Wang N, Roberts DM, Graham GG, Williams KM, Day RO. Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012. Drug Saf 2013;36:953-80. [Ref.ID 96270]
Day RO, Graham GG. Non-steroidal anti-inflammatory drugs (NSAIDs). BMJ 2013;347:34-7. [Ref.ID 96140]
9.Enlace a cita original
Abdul MiM, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, Matthias A, Lehmann RP, MacLachlan AJ. Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects. Br J Clin Pharmacol 2010;69:508-15. [Ref.ID 88440]
10.Tiene citas relacionadas Cita con resumen
Westbrook JI, Woods A, Rob MI, Dunsmuir WTM, Day RO. Association of interruptions with an increased risk and severity of medication administration errors. Arch Intern Med 2010;170:683-90. [Ref.ID 88424]
12.Tiene citas relacionadas Cita con resumen
Hancock MJ, Maher CG, Latimer J, McLachlan AJ, Cooper CW, Day RO, Spindler MF, McAuley JH. Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial. Lancet 2007;370:1638-43. [Ref.ID 81484]
14. Cita con resumen
Day RO, Williams KM. Open-label extension studies: do they provide meaningful information on the safety of new drugs?. Drug Saf 2007;30:93-105. [Ref.ID 79290]
Jiang X-M, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005;59:425-32. [Ref.ID 73530]
16. Cita con resumen
Graham GG, Scott KF, Day RO. Tolerability of paracetamol. Drug Saf 2005;28:227-40. [Ref.ID 73085]
Day RO, McLachlan AJ, Graham GG, Williams KM. Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 1999;36:191-210. [Ref.ID 43938]
18. Cita con resumen
Weekes LM, Brooks C, Day RO. Indicators for drug and therapeutics committees. Br J Clin Pharmacol 1998;45:393-8. [Ref.ID 38394]
Quinn DI, Wodak A, Day RO. Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users. Clin Pharmacokinet 1997;33:344-400. [Ref.ID 35588]
Seleccionar todas
 1 a 20 de 32 siguiente >>